Drug interactions
Dexamethasone-tobramycin + Netupitant / palonosetron
Severity: Minor
Dexamethasone-tobramycin and Netupitant / palonosetron: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dexamethasone is a weak-to-moderate CYP3A4 inducer, but it is routinely given with netupitant/palonosetron for chemotherapy-induced nausea. Netupitant also raises dexamethasone exposure through CYP3A4 inhibition. Clinically significant loss of antiemetic effect is not expected.
What this interaction means in plain words
Dexamethasone-tobramycin and Netupitant / palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Dexamethasone may modestly induce CYP3A4, while netupitant inhibits CYP3A4 and increases dexamethasone levels.
What to do
Use the combination as labeled, reducing the oral dexamethasone dose when given with netupitant for antiemesis. No other intervention is needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and Netupitant / palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Frequently asked questions
Can I take Dexamethasone-tobramycin with Netupitant / palonosetron?
MediHelp rates the interaction as minor. Dexamethasone-tobramycin and Netupitant / palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dexamethasone is a weak-to-moderate CYP3A4 inducer, but it is routinely given with netupitant/palonosetron for chemotherapy-induced nausea. Netupitant also raises dexamethasone exposure through CYP3A4 inhibition. Clinically significant loss of antiemetic effect is not expected.
How serious is the interaction between Dexamethasone-tobramycin and Netupitant / palonosetron?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the combination as labeled, reducing the oral dexamethasone dose when given with netupitant for antiemesis. No other intervention is needed.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
